Latest Health in the People's Republic of China Stories

Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation

2013-01-31 08:31:01

SANDY, Utah, Jan. 31, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals, Inc. (the "Company") OTC symbol "RAFA" announced that it has been named one of the four national strategic Pharmaceutical Suppliers to the Russian Federation. This important step for the company means it will receive guaranteed government contracts helping load the manufacturing facility to 100% capacity. The Russian pharmaceutical industry supplies both the national health care system and hospital sector with 70%...

Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call

2013-01-30 08:30:36

ALISO VIEJO, Calif., Jan. 30, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended December 31, 2012 after market close on Thursday February 7, 2013. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day. Conference Call Information:Domestic callers: 1 (866) 783-2141International callers: +1 (857) 350-1600Passcode: 51423033 Webcast...

ScinoPharm and Foresee Pharmaceuticals Entered into an Agreement to Establish a Joint Venture for Developing Novel Oncological Peptide Drugs

2013-01-30 04:21:07

TAINAN, Taiwan, Jan. 30, 2013 /PRNewswire/ -- ScinoPharm (TWSE: 1789) and Foresee Pharmaceuticals, Inc. (Foresee) jointly announced today that an investment agreement to form a joint venture has been signed. This venture looks to develop a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug product, where Leuprolide will be formulated in a proprietary controlled-release drug delivery system originally developed by Foresee and...

Aoxing Pharmaceutical Company, Inc. Announces Receipt Of Production License For Pholcodine

2013-01-28 08:28:47

JERSEY CITY, N.J., Jan. 28, 2013 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced that its Chinese subsidiary has received from the State Food and Drug Administration of China ("SFDA") a license to produce the active pharmaceutical ingredient ("API") in...

China Botanic Appoints Jack Zhao as Independent Director

2013-01-24 08:31:20

HARBIN, China, Jan. 24, 2013 /PRNewswire/ -- China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines ("TCM") in China, today announced the appointment of Mr. Jack Zhao as a member of the Company's Board of Directors. Mr. Zhao will serve as an independent director, the Chairman of the Board's Audit Committee, the Audit Committee...

Dyadic International Upgraded By OTC Markets To "Current Information" Tier

2013-01-23 08:23:23

JUPITER, Fla., Jan. 23, 2013 /PRNewswire/ -- Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals and industrial enzyme industries, announced today that it has been upgraded by OTC Markets to "Current Information" which is the highest trading tier on the OTC Pink marketplace. The disclosures required for this upgrade have been...

Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen

2013-01-22 04:22:04

NANJING, China, Jan. 22, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15(th) 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co.,...

Award-winning Speakers Are Meeting at the Global Pharma Manufacturing Summit 2013

2013-01-16 12:27:23

BOSTON, January 16, 2013 /PRNewswire/ -- Event dates and location: 8th Annual Global Pharma Manufacturing Summit 2013 June 27th-28th 2013 The Westin Copley Place, Boston, US http://www.gpmsummit.com Now in its eighth year, the Global Pharma Manufacturing Summit presents premier networking opportunities for pharma manufacturing industry leaders to discuss and share their expertise. Over 150 senior executives and...

China Botanic Pharmaceutical Inc. Announces Receipt of Warning Letter

2013-01-15 07:17:44

HARBIN, China, Jan. 15, 2013 /PRNewswire/ -- China Botanic Pharmaceutical Inc. (AMEX: CBP) (formerly Renhuang Pharmaceuticals, Inc.) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, announced today that it received a warning letter from the NYSE MKT LLC ("NYSE MKT") that the Company is not in compliance with Section 803(B)(2)(a)(iii) of the NYSE MKT LLC Company...

Konsyl Pharmaceuticals, Inc. Announces New Vice President of Sales and Marketing

2013-01-14 23:00:22

Experienced sales and marketing executive Roger Giannico to lead brand in new growth strategy. Easton, MD (PRWEB) January 14, 2013 Konsyl Pharmaceuticals, Inc. (http://www.konsyl.com), a subsidiary of ICC Industries Inc., is pleased to announce the appointment of Roger Giannico as its Vice President of Sales and Marketing. Mr. Giannico has over 25 years of experience in health care product sales and marketing management, most recently at ChaseHealthAdvance Patient Financing, a division of...